Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Piramal Pharma Limited has filed a routine regulatory disclosure providing updated contact details of its Key Managerial Personnel (KMP) as required under SEBI Listing Regulations. The filing lists two KMPs: Mr. Vivek Valsaraj (Chief Financial Officer) at vivek.valsaraj@piramal.com and Mr. Maneesh Sharma (Company Secretary and Compliance Officer) at maneesh.sharma2@piramal.com. This disclosure is mandated under Regulation 30(5) which requires listed companies to designate personnel responsible for determining materiality of events and making exchange disclosures. The company filed this with both BSE (scrip code: 543635) and NSE (symbol: PPLPHARMA) on April 29, 2026.
This is a routine compliance filing with no direct impact on the company's financials or stock price. It simply updates stakeholder contact information for regulatory purposes.